Patel Naimish 4
4 · CRISPR Therapeutics AG · Filed May 29, 2024
Insider Transaction Report
Form 4
Patel Naimish
Chief Medical Officer
Transactions
- Award
Restricted Stock Units
2024-05-28+40,000→ 40,000 total→ Common Shares (40,000 underlying) - Award
Stock Option (Right to Buy)
2024-05-28+85,000→ 85,000 totalExercise: $54.84Exp: 2034-05-28→ Common Shares (85,000 underlying)
Footnotes (3)
- [F1]This option was granted on May 28, 2024 with respect to 85,000 Common Shares. 25% of the shares shall vest on May 28, 2025, and the remaining shares shall vest in 36 equal monthly installments thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
- [F3]This restricted stock unit award was granted on May 28, 2024 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on May 28, 2025, (ii) one quarter of the shares vesting on May 28, 2026, (iii) one quarter of the shares vesting on May 28, 2027, and (iv) one quarter of the shares vesting on May 28, 2028.